Saffron for the Management of Premenstrual Dysphoric Disorder: A Randomized Controlled Trial

BACKGROUND: Selective serotonin reuptake inhibitors are among the most common agents have been used for the treatment of the premenstrual dysphoric disorder (PMDD); however, due to the diversity in the outcomes and adverse effects, efforts are in progress to find an agent with maximal efficacy and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajabi, Fatemeh, Rahimi, Marjan, Sharbafchizadeh, Mohammad Reza, Tarrahi, Mohammad Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792881/
https://www.ncbi.nlm.nih.gov/pubmed/33457343
http://dx.doi.org/10.4103/abr.abr_49_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792881/
https://www.ncbi.nlm.nih.gov/pubmed/33457343
http://dx.doi.org/10.4103/abr.abr_49_20

Ejemplares similares